Calprotectin Degradation by Human Neutrophil Elastase, Measured by a Novel Serological Biomarker, Is Elevated in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, and Lung Cancer

MLA

M. Karsdal, et al. “Calprotectin Degradation by Human Neutrophil Elastase, Measured by a Novel Serological Biomarker, Is Elevated in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, and Lung Cancer.” TP109. TP109 COPD AND E-CIGARETTES: PRE-CLINICAL MODELS AND MECHANISMS, May 2021. EBSCOhost, https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4294.

APA

M. Karsdal, Joachim Høg Mortensen, D.J. Leeming, Sarah Rønnow, J.M.B. Sand, A.H. Hansen, & A.-C. Bay-Jensen. (2021). Calprotectin Degradation by Human Neutrophil Elastase, Measured by a Novel Serological Biomarker, Is Elevated in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, and Lung Cancer. TP109. TP109 COPD AND E-CIGARETTES: PRE-CLINICAL MODELS AND MECHANISMS. https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4294

Chicago

M. Karsdal, Joachim Høg Mortensen, D.J. Leeming, Sarah Rønnow, J.M.B. Sand, A.H. Hansen, and A.-C. Bay-Jensen. 2021. “Calprotectin Degradation by Human Neutrophil Elastase, Measured by a Novel Serological Biomarker, Is Elevated in Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, and Lung Cancer.” TP109. TP109 COPD AND E-CIGARETTES: PRE-CLINICAL MODELS AND MECHANISMS, May. doi:10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a4294.